AstraZeneca CEO Raises Bar for Deals After Acquisitions Spree

  • `We have what we need to have,' Soriot tells journalists
  • Any purchase would need to be immediately accretive, CEO says

AstraZeneca Plc pledged to only pursue acquisitions that immediately add to the drugmaker’s bottom line, following a deal spree in the last quarter of 2015.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.